Pfizer Inc (NYSE:PFE)
| 33.17 Delayed Data As of Sep 29 |  +1.08 / +3.38%Today’s Change | 31.77 Today|||52-Week Range 54.93 | -35.26% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Bourla Albert Chairman & Chief Executive Officer |  Buy | 12/16/2022 | 133,172 | $30.17 | $4.0M | -35.47% |
Bourla Albert Chairman & Chief Executive Officer |  Sale | 2/22/2023 | 61,994 | $42.38 | $2.6M | -21.73% |
Susman Sally Executive Vice President | Buy | 2/22/2023 | 76,043 | $30.17 | $2.3M | -21.73% |
Bourla Albert Chairman & Chief Executive Officer | Buy | 12/16/2022 | 89,156 | $22.89 | $2.0M | -35.47% |
Susman Sally Executive Vice President | Sale | 2/22/2023 | 46,291 | $43.70 | $2.0M | -21.73% |
Bourla Albert Chairman & Chief Executive Officer | Sale | 2/25/2023 | 43,419 | $41.75 | $1.8M | -18.66% |
Hwang Angela | Buy | 2/22/2023 | 57,032 | $30.17 | $1.7M | -21.73% |
Susman Sally Executive Vice President | Buy | 2/25/2023 | 72,984 | $22.89 | $1.7M | -18.66% |
Dolsten Mikael President-Research & Development | Sale | 2/25/2023 | 37,078 | $41.75 | $1.5M | -18.66% |
Dolsten Mikael President-Research & Development | Buy | 11/07/2022 | 50,938 | $30.17 | $1.5M | -29.56% |
Page of 6